Literature DB >> 18639734

Sensorineural hearing loss in primary antibody deficiency disorders.

Marco Berlucchi1, Annarosa Soresina, Luca O Redaelli De Zinis, Luisa Valetti, Roberta Valotti, Vassilios Lougaris, Antonella Meini, Daria Salsi, Piero Nicolai, Alessandro Plebani.   

Abstract

To evaluate the hearing function in patients affected by primary antibody deficiency disorders. Forty-seven patients, 25 of whom were affected by X-linked agammaglobulinemia and 22 of whom were affected by common variable immunodeficiency were evaluated with audiologic tests that included pure tone audiometry, acoustic immittance assessment and auditory brainstem-evoked response. Eighteen patients (38%), 7 with X-linked agammaglobulinemia and 11 with common variable immunodeficiency, showed sensorineural hearing loss, bilateral in 12 and unilateral in 6. Our data underline the high frequency of hearing loss in patients with antibody deficiency and suggest that a systematic audiologic evaluation should be part of the clinical care of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639734     DOI: 10.1016/j.jpeds.2008.03.008

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 2.  Primary immunodeficiency for the primary care provider.

Authors:  A W O'Keefe; M Halbrich; M Ben-Shoshan; C McCusker
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

3.  Sensorineural Hearing Loss in Selective Immunglobulin A Deficiency.

Authors:  Erkan Eşki; Belgin Emine Usta; Suna Asilsoy; İsmail Yılmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

4.  Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases.

Authors:  Stephan Borte; Magdalena Janzi; Qiang Pan-Hammarström; Ulrika von Döbeln; Lennart Nordvall; Jacek Winiarski; Anders Fasth; Lennart Hammarström
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.